|
1
|
Dasgupta R and Rodeberg DA: Update on
rhabdomyosarcoma. Semin Pediatr Surg. 21:68–78. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Huh WW and Skapek SX: Childhood
rhabdomyosarcoma: New insight on biology and treatment. Curr Oncol
Rep. 12:402–410. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Leaphart C and Rodeberg D: Pediatric
surgical oncology: Management of rhabdomyosarcoma. Surg Oncol.
16:173–185. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Ray A and Huh WW: Current state-of-the-art
systemic therapy for pediatric soft tissue sarcomas. Curr Oncol
Rep. 14:311–319. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Turner JH and Richmon JD: Head and neck
rhabdomyosarcoma: A critical analysis of population-based incidence
and survival data. Otolaryngol Head Neck Surg. 145:967–973. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Pappo AS, Shapiro DN, Crist WM and Maurer
HM: Biology and therapy of pediatric rhabdomyosarcoma. J Clin
Oncol. 13:2123–2139. 1995.PubMed/NCBI
|
|
7
|
Miller RW, Young JL Jr and Novakovic B:
Childhood cancer. Cancer. 75(Suppl 1): S395–S405. 1995. View Article : Google Scholar
|
|
8
|
Holsinger FC, Weeks BH, Hicks MJ and
Friedman EM: Contemporary concepts in the management of pediatric
rhabdomyosarcoma. Curr Opin Otolaryngol Head Neck Surg. 10:91–96.
2002. View Article : Google Scholar
|
|
9
|
Hayes-Jordan A and Andrassy R:
Rhabdomyosarcoma in children. Curr Opin Pediatr. 21:373–378. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Ahmed AA and Tsokos M: Sinonasal
rhabdomyosarcoma in children and young adults. Int J Surg Pathol.
15:160–165. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Stevens MC: Treatment for childhood
rhabdomyosarcoma: The cost of cure. Lancet Oncol. 6:77–84. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Wachtel M, Dettling M, Koscielniak E,
Stegmaier S, Treuner J, Simon-Klingenstein K, Bühlmann P, Niggli FK
and Schäfer BW: Gene expression signatures identify
rhabdomyosarcoma subtypes and detect a novel t(2;2)(q35;p23)
translocation fusing PAX3 to NCOA1. Cancer Res. 64:5539–5545. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Gradoni P, Giordano D, Oretti G, Fantoni M
and Ferri T: The role of surgery in children with head and neck
rhabdomyosarcoma and Ewing's sarcoma. Surg Oncol. 19:e103–109.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Rodeberg DA, Paidas CN, Lobe TL, Brown K,
Andrassy RJ, Crist WM and Wiener ES: Surgical principles for
children/adolescents with newly diagnosed rhabdomyosarcoma: A
report from the Soft Tissue Sarcoma Committee of the Children's
Oncology Group. Sarcoma. 6:111–122. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Zalewska-Szewczyk B, Kazanowska B,
Mlynarski W, Dłużniewska A, Drożyńska E, Kurylak A, Nurzyńska-Flak
J, Rybczyńska A, Pietniczka-Załęska M, Rychłowska-Pruszyńska M, et
al: The analysis of clinical course and outcome of soft tissue
sarcoma in parameningeal localization in children treated according
to the CWS 96 protocol - a report of the Polish Paediatric Solid
Tumours Group. Wspolczesna Onkol. 12:116–120. 2008.
|
|
16
|
Kazanowska B, Reich A, Reich M, Balcerska
A, Balwierz W, Bodalski J, Dłuzniewska A, Drozyńska E, Katski K,
Kijowski J, et al: Remaining problems and controversies in the
management of childhood head and neck soft tissue sarcomas:
Retrospective (national) Multicenter Study of the Polish Pediatric
Solid Tumors Group. Pediatr Hematol Oncol. 21:349–362. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Radzikowska J, Kukwa W, Kukwa A, Czarnecka
A and Krzeski A: Rhabdomyosarcoma of the head and neck in children.
Contemp Oncol (Pozn). 19:98–107. 2015.PubMed/NCBI
|
|
18
|
McNall-Knapp RY, Williams CN, Reeves EN,
Heideman RL and Meyer WH: Extended phase I evaluation of
vincristine, irinotecan, temozolomide, and antibiotic in children
with refractory solid tumors. Pediatr Blood Cancer. 54:909–915.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Wagner LM, Perentesis JP, Reid JM, Ames
MM, Safgren SL, Nelson MD Jr, Ingle AM, Blaney SM and Adamson PC:
Phase I trial of two schedules of vincristine, oral irinotecan, and
temozolomide (VOIT) for children with relapsed or refractory solid
tumors: A Children's Oncology Group phase I consortium study.
Pediatr Blood Cancer. 54:538–545. 2010.PubMed/NCBI
|
|
20
|
Casanova M, Ferrari A, Bisogno G, Merks
JHM, De Salvo GL, Meazza C, Tettoni K, Provenzi M, Mazzarino I and
Carli M: Vinorelbine and low-dose cyclophosphamide in the treatment
of pediatric sarcomas: Pilot study for the upcoming European
Rhabdomyosarcoma Protocol. Cancer. 101:1664–1671. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Rapkin L, Qayed M, Brill P, Martin M,
Clark D, George BA, Olson TA, Wasilewski-Masker K, Alazraki A and
Katzenstein HM: Gemcitabine and docetaxel (GEMDOX) for the
treatment of relapsed and refractory pediatric sarcomas. Pediatr
Blood Cancer. 59:854–858. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Kazanowska B and Chybicka A: Nowotwory
tkanek miękkichZalecenia Postępowania Diagnostyczno -
Terapeutycznego W Nowotworach Złośliwych. Krzakowski M: 1st. Via
Medica Gdansk; Gdańsk: pp. 868–893. 2012, (In Polish).
|
|
23
|
Lawrence W Jr, Anderson JR, Gehan EA and
Maurer H: Children's Cancer Study Group: Pretreatment TNM staging
of childhood rhabdomyosarcoma: A report of the Intergroup
Rhabdomyosarcoma Study Group Pediatric Oncology Group. Cancer.
80:1165–1170. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Dito WR and Batsakis JG: Rhabdomyosarcoma
of the head and neck. An appraisal of the biologic behavior in 170
cases. Arch Surg. 84:582–588. 1962. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Healy GB, Upton J, Black PM and Ferraro N:
The Role of surgery in rhabdomyosarcoma of the head and neck in
children. Arch Otolaryngol Head Neck Surg. 117:1185–1188. 1991.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Masson JK and Soule EH: Embryonal
rhabdomyosarcoma of head and neck. Report on eighty-eight cases. Am
J Surg. 110:585–591. 1965.
|
|
27
|
Gosiengfiao Y, Reichek J and Walterhouse
D: What is new in rhabdomyosarcoma management in children? Pediatr
Drugs. 14:389–400. 2012. View Article : Google Scholar
|
|
28
|
Smith LM, Anderson JR, Qualman SJ, Crist
WM, Paidas CN, Teot LA, Pappo AS, Link MP, Grier HE, Wiener ES, et
al: Which patients with microscopic disease and rhabdomyosarcoma
experience relapse after therapy? A report from the soft tissue
sarcoma committee of the children's oncology group. J Clin Oncol.
19:4058–4064. 2001.PubMed/NCBI
|
|
29
|
Estilo CL, Huryn JM, Kraus DH, Sklar CA,
Wexler LH, Wolden SL and Zlotolow IM: Effects of therapy on
dentofacial development in long-term survivors of head and neck
rhabdomyosarcoma: The memorial sloan-kettering cancer center
experience. J Pediatr Hematol Oncol 25: 215–222, 2003.
Holsinger
FC, Weeks BH, Hicks MJ and Friedman EM: Contemporary concepts in
the management of pediatric rhabdomyosarcoma. Current Opinion in
Otolaryngology & Head and Neck Surgery. 10:91–96. 2002.
|
|
30
|
Dickson PV and Davidoff AM: Malignant
neoplasms of the head and neck. Semin Pediatr Surg. 15:92–98. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Daya H, Chan HS, Sirkin W and Forte V:
Pediatric rhabdomyosarcoma of the head and neck: Is there a place
for surgical management? Arch Otolaryngol Head Neck Surg.
126:468–472. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Walterhouse D and Watson A: Optimal
management strategies for rhabdomyosarcoma in children. Paediatr
Drugs. 9:391–400. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Wharam MD, Meza J, Anderson J, Breneman
JC, Donaldson SS, Fitzgerald TJ, Michalski J, Teot LA, Wiener ES
and Meyer WH: Failure pattern and factors predictive of local
failure in rhabdomyosarcoma: A report of group III patients on the
third Intergroup Rhabdomyosarcoma Study. J Clin Oncol.
22:1902–1908. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Crist W, Gehan EA, Ragab AH, Dickman PS,
Donaldson SS, Fryer C, Hammond D, Hays DM, Herrmann J, Heyn R, et
al: The Third Intergroup Rhabdomyosarcoma Study. J Clin Oncol.
13:610–630. 1995.PubMed/NCBI
|
|
35
|
Dagher R and Helman L: Rhabdomyosarcoma:
An overview. Oncologist. 4:34–44. 1999.PubMed/NCBI
|
|
36
|
Moretti G, Guimarães R, Oliveira KM,
Sanjar F and Voegels RL: Rhabdomyosarcoma of the head and neck: 24
cases and literature review. Braz J Otorhinolaryngol. 76:533–537.
2010.(In English, Portuguese). View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Fyrmpas G, Wurm J, Athanassiadou F,
Papageorgiou T, Beck JD, Iro H and Constantinidis J: Management of
paediatric sinonasal rhabdomyosarcoma. J Laryngol Otol.
123:990–996. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
McCarville MB: Imaging techniques used in
the diagnosis of pediatric tumorsPediatric Malignancies: Pathology
and Imaging. Parham DM, Khoury JD and McCarville MB: Springer
Science and Business Media; New York, NY: pp. 7–18. 2015
|
|
39
|
Brody AS, Frush DP, Huda W and Brent RL:
American Academy of Pediatrics Section on Radiology. Radiation risk
to children from computed tomography. Pediatrics. 120:677–682.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Brenner D, Elliston C, Hall E and Berdon
W: Estimated risks of radiation-induced fatal cancer from pediatric
CT. AJR Am J Roentgenol. 176:289–296. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Walter F, Czernin J, Hall T,
Allen-Auerbach M, Walter MA, Dunkelmann S and Federman N: Is there
a need for dedicated bone imaging in addition to 18F-FDG PET/CT
imaging in pediatric sarcoma patients? J Pediatr Hematol Oncol.
34:131–136. 2012. View Article : Google Scholar : PubMed/NCBI
|
